Cargando…

Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial

BACKGROUND/AIMS: Eradication of Helicobacter pylori infection with standard triple therapy (TT) has declined primarily because of increased antibiotic resistance. Sequential therapy (ST) has been suggested as an alternative to TT for the first-line treatment of H. pylori. The purpose of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Joon Sung, Kim, Byung-Wook, Hong, Su Jin, Kim, Jin Il, Shim, Ki-Nam, Kim, Jie-Hyun, Baik, Gwang Ho, Kim, Sang Wook, Song, Hyun Joo, Kim, Ji Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933415/ https://www.ncbi.nlm.nih.gov/pubmed/27114421 http://dx.doi.org/10.5009/gnl15470

Ejemplares similares

Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea
por: Kim, Beom Jin, et al.
Publicado: (2019)

The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea
por: Chung, Kwang Hyun, et al.
Publicado: (2014)

Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis
por: Kim, Joon Sung, et al.
Publicado: (2013)

Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis
por: Kim, Beom Jin, et al.
Publicado: (2016)

Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success
por: Kim, Beom Jin, et al.
Publicado: (2019)

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
por: Chang, Ji Young, et al.
Publicado: (2017)

Long-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori
por: Seo, Jae Hyun, et al.
Publicado: (2016)

Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea
por: Yoon, Kyu-Hyun, et al.
Publicado: (2014)

Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016
por: Lee, Jeong Hoon, et al.
Publicado: (2018)

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Correction to: Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
por: Lee, Ju Yup, et al.
Publicado: (2016)

Prevalence and risk factors of Helicobacter pylori infection in Korea: Nationwide multicenter study over 13 years
por: Lim, Seon Hee, et al.
Publicado: (2013)

Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
por: Jung, Sung Min, et al.
Publicado: (2016)

Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial
por: Choi, Yoon Jin, et al.
Publicado: (2022)

Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection
por: Bang, Chang Seok, et al.
Publicado: (2015)

Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?
por: Jeon, Hye Kyung, et al.
Publicado: (2014)

Effect of Helicobacter pylori Eradication on the Development of Reflux Esophagitis and Gastroesophageal Reflux Symptoms: A Nationwide Multi-Center Prospective Study
por: Kim, Nayoung, et al.
Publicado: (2011)

Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis
por: Lee, Sang Wook, et al.
Publicado: (2015)

Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?
por: Gong, Eun Jeong, et al.
Publicado: (2014)

Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication
por: Yoon, Jai Hoon, et al.
Publicado: (2012)

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
por: Lim, Joo Hyun, et al.
Publicado: (2017)

Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea
por: Moon, Ji Yoon, et al.
Publicado: (2013)

Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: A cross-sectional nationwide multicenter study
por: Lim, Seon Hee, et al.
Publicado: (2018)

Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021)

Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial
por: Seo, Seung In, et al.
Publicado: (2022)

Helicobacter pylori and Molecular Markers as Prognostic Indicators for Gastric Cancer in Korea
por: Kim, Hee Jin, et al.
Publicado: (2014)

Is Helicobacter pylori Associated Functional Dyspepsia Correlated With Dysbiosis?
por: Kim, Yeon-Ji, et al.
Publicado: (2017)

Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial
por: Yoon, Hyuk, et al.
Publicado: (2016)

Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
por: Kim, Sung Eun, et al.
Publicado: (2015)

Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020)

Effect of Helicobacter pylori Eradication on Functional Dyspepsia
por: Kim, Sung Eun, et al.
Publicado: (2013)

Antibiotic Resistance in Helicobacter pylori Strains and its Effect on H. pylori Eradication Rates in a Single Center in Korea
por: An, Byoungrak, et al.
Publicado: (2013)

Dual Therapy Trial Using Esomeprazole and Amoxicillin as Third-line Rescue Therapy for Helicobacter pylori Infection
por: Park, Hyun Kyung, et al.
Publicado: (2011)

Quantitative multiplex real-time polymerase chain reaction assay for the detection of Helicobacter pylori and clarithromycin resistance
por: Kim, Ilsoo, et al.
Publicado: (2023)

Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
por: Kim, Min Soo, et al.
Publicado: (2013)

The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication
por: Choe, Younghee, et al.
Publicado: (2022)

Correction: Quantitative multiplex real-time polymerase chain reaction assay for the detection of Helicobacter pylori and clarithromycin resistance
por: Kim, Ilsoo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ufgg9cpje5c1kuejq5m7pbsl8q